Lv11
18 积分 2025-09-12 加入
Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance
2小时前
待确认
Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC
2个月前
已完结
Pharmacokinetics and Pharmacodynamic of Alpelisib
1年前
已完结
DB-1303, a HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising safety profile and anti-tumor efficacy with differentiation from DS-8201a
1年前
已完结
皖公网安备34019202002308
